Results 161 to 170 of about 213,305 (310)

Regional Differences, Distributional Dynamics and Spatial Convergence of Pharmacist Human Resources in China: A Healthcare Tiers Difference Perspective

open access: yesRisk Management and Healthcare Policy
Bo Ding,1 Run Zhao,2 Xinyi Yue,2 Dexun Li2 1Pharmacy Department, Hefei Maternal and Child Health Hospital, Hefei, People’s Republic of China; 2School of Pharmaceutical Economics and Management, Anhui University of Chinese Medicine, Hefei, People’s ...
Ding B, Zhao R, Yue X, Li D
doaj  

Promoting Safe Opioid Disposal: Experimental Evidence on Behavioral Messaging With Financial Incentives

open access: yesHealth Economics, EarlyView.
ABSTRACT Some patients prescribed opioid pills fail to properly dispose of their unused pills, posing a risk for others. We report results from a pre‐registered field experiment testing whether behaviorally informed reminder cards increase participation in a financial incentive program for returning unused opioid pills among U.S. Veterans.
Mattie Toma   +7 more
wiley   +1 more source

Pharmaceutical Economics?

open access: yesAmerican Journal of Pharmaceutical Education, 1940
openaire   +1 more source

Unintended Consequences of Life‐Saving Pharmaceutical Innovations: How HAART Led to the Resurgence of Syphilis

open access: yesHealth Economics, EarlyView.
ABSTRACT Syphilis, a sexually transmitted infection that can lead to serious health complications, was almost eliminated in the United States by 2000. But since then, its incidence began to increase, recently reaching a 60‐year peak. We suggest that the introduction of the highly active antiretroviral therapy (HAART) drug regimen, which transformed HIV
David Beheshti   +2 more
wiley   +1 more source

Essays in Pharmaceutical Economics

open access: yes, 2016
This doctoral dissertation incorporates formal industrial organization and mechanism design analysis in the pharmaceutical industry in order to expand our understanding of modern pharmaceutical markets and provide new insights to key policy questions. The focus is primarily on the supply side of the pharmaceutical sector and in particular on questions ...
openaire   +1 more source

Pharmaceutical Pricing and R&D as a Global Public Good

open access: yesHealth Economics, EarlyView.
ABSTRACT This paper examines the international variation in the prices of branded pharmaceuticals. We consider short‐run profits, or quasi‐rents, as representing each country's contribution toward the global public good of therapeutic information embodied in new pharmaceuticals.
H. E. Frech III   +3 more
wiley   +1 more source

Pharmaceutical Economics in the Postwar Curriculum

open access: yesAmerican Journal of Pharmaceutical Education, 1947
openaire   +2 more sources

Home - About - Disclaimer - Privacy